A Phase Ib Study of CT053PTSA in Relapsed / Refractory Acute Myeloid Leukemia (AML)

Clinical trial NCT03125876 · TERMINATED

Trial details

NCT number: NCT03125876
Sponsor: Sunshine Lake Pharma Co., Ltd.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML)

Start date: 2017-11-13
Primary completion: 2019-08-19
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.